Ani Pharmaceuticals, Inc. · NASDAQ:ANIP
Rowland Thomas Andrew sold 459 Ani Pharmaceuticals, Inc. shares (Form 4)
Traded May 12, 2026 · Filed May 13, 2026
On May 12, 2026, Rowland Thomas Andrew (SVP, HEAD - ESTABLISHED BRANDS) sold 459 Ani Pharmaceuticals, Inc. shares at US$79.21 for US$36,357, leaving 38,271 shares. Filed May 13, 2026 (Form 4).
- Sold
- 459 shares
- Price
- US$79.21
- Value
- US$36,357
- Holding after
- 38,271 shares
- Trading plan
- No
- Role
- SVP, HEAD - ESTABLISHED BRANDS
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 12, 2026 | Common Stock | Sale | 459 | US$79.21 | 38,271 | Direct |